Tag: chemoBrain
Articles
- Latest research concerning side effects of chemotherapy
- Latest research on chemo brain after breast cancer treatment
- Latest research on factors influencing Adriamycin (doxorubicin) effectiveness
- Latest research on factors influencing Taxol (paclitaxel) effectiveness
News
- Breast cancer survivors may experience brain changes similar to post traumatic stress
- Chemo brain can persist for more than three years after breast cancer treatment
- Chemotherapy might cause chemo brain by disrupting the formation of brain nerve cells
- Chemotherapy results in measurable reductions in brain gray matter
- Degree of chemo brain appears to be influenced by age and cognitive reserve
- Radiation treatment can result in persistent fatigue
- Women undergoing breast conserving treatment can have ongoing side effects
Studies
- Anti-inflammatory drugs reduce age-related decreases in brain volume in cognitively normal older adults
- Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval
- Cancer linked to Alzheimer disease but not vascular dementia
- Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial
- Cognitive functioning after cancer treatment
- Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment
- Does Cancer Protect Against Alzheimer Disease or Vice Versa?: New Data from a Large Population‐Based Study
- Effects of doxorubicin on brain activity and resting-state functional connectivity in rats: fMRI studies
- Effects of herbal and dietary supplements on cognition in menopause: A systematic review
- Effects of multiple daily genistein treatments on delayed alternation and a differential reinforcement of low rates of responding task in middle-aged rats
- Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
- Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer
- Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
- Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
- Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study
- Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging
- Long-term toxic effects of adjuvant chemotherapy in breast cancer
- Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
- Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
- Longitudinal Impact of Yoga on Chemotherapy-Related Cognitive Impairment and Quality of Life in Women with Early Stage Breast Cancer: A Case Series
- Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
- One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer
- Patterns of Dementia Diagnosis in Surveillance, Epidemiology, and End Results Breast Cancer Survivors Who Use Chemotherapy
- Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer
- Relationship Between Chemotherapy Use and Cognitive Impairments in Older Women With Breast Cancer: Findings From a Large Population-Based Cohort
- Risk of Dementia in Older Breast Cancer Survivors: A Population-Based Cohort Study of the Association with Adjuvant Chemotherapy
- Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
- Symptom Management of Affective and Cognitive Disturbance With a Group of Cancer Survivors
- The role of neurogenesis in post-chemotherapy cognitive impairment